跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
DEMYLOCAN
Authorized
STANDARD
DEMYLOCAN
pendopharm division of pharmascience inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7b21a2d8ccc92cf5
Company
pendopharm division of pharmascience inc
Type
Standard
Approval Details
Approval Id
7b21a2d8ccc92cf5
Drug Approval Canada Name
DEMYLOCAN
Product Name
DEMYLOCAN
Status
Marketed
Status Date
2021-03-24
Original Market Date
2021-03-24
Din
02484811
Drug Class
Human
Dosage Form
Powder
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BC08 DECITABINE
Atc Name
l 01 bc 08
Aig Number
0161170001
Company Name
pendopharm division of pharmascience inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Active Ingredients
DECITABINE
50 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7b21a2d8ccc92cf5
Type
Standard
Back to Health Canada Approvals
DEMYLOCAN - Health Canada Drug Approval Details